Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD300LG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
POU5F1P3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HHIPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRAMEF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SMARCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM49A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF565 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PANX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on